Immage Biotherapeutics Corp.
IMMG
$0.00
$0.000.00%
OTC PK
02/28/2017 | 11/30/2016 | 08/31/2016 | 05/31/2016 | 02/29/2016 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 53.70K | 127.10K | 196.70K | 265.50K | 327.80K |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 3.30K | 5.80K | 8.30K | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 57.00K | 133.00K | 205.00K | 265.50K | 327.80K |
|
|||||
Total Current Assets | 57.00K | 133.00K | 205.00K | 265.50K | 327.80K |
Net Property, Plant & Equipment | 28.10K | 30.10K | 32.20K | 34.20K | 36.30K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 5.70K | 5.80K | 5.90K | 5.40K | 5.70K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 90.80K | 168.90K | 243.10K | 305.10K | 369.70K |
|
|||||
Total Accounts Payable | 12.20K | 48.20K | 3.00K | 3.10K | 16.80K |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | 56.30K | 54.30K | 52.80K | 52.80K | 52.80K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 68.50K | 102.50K | 55.80K | 55.80K | 69.60K |
|
|||||
Total Current Liabilities | 68.50K | 102.50K | 55.80K | 55.80K | 69.60K |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 56.30K | 54.30K | 52.80K | 52.80K | 52.80K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 68.50K | 102.50K | 55.80K | 55.80K | 69.60K |
|
|||||
Common Stock & APIC | 2.04M | 2.04M | 490.10K | 490.10K | 490.10K |
Retained Earnings | -2.02M | -1.97M | -302.80K | -240.80K | -190.00K |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 22.30K | 66.40K | 187.30K | 249.30K | 300.10K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 22.30K | 66.40K | 187.30K | 249.30K | 300.10K |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 22.30K | 66.40K | 187.30K | 249.30K | 300.10K |
|